Showing 1 - 3 results of 3 for search 'Clemence Pouzin', query time: 0.05s Refine Results
  1. 1
    Covariate analysis of tusamitamab ravtansine, a DM4 anti‐CEACAM5 antibody‐drug conjugate, based on first‐in‐human study

    Covariate analysis of tusamitamab ravtansine, a DM4 anti‐CEACAM5 antibody‐drug conjugate, based on first‐in‐human study by Clemence Pouzin, Michel Tod, Mustapha Chadjaa, Nathalie Fagniez, Laurent Nguyen

    Published 2022
    Loading…
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    A multi‐model approach to predict efficacious clinical dose for an anti‐TGF‐β antibody (GC2008) in the treatment of osteogenesis imperfecta

    A multi‐model approach to predict efficacious clinical dose for an anti‐TGF‐β antibody (GC2008) in the treatment of osteogenesis imperfecta by Panteleimon D. Mavroudis, Nikhil Pillai, Qingping Wang, Clemence Pouzin, Benjamin Greene, Jennifer Fretland

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    Safety, pharmacokinetics, pharmacodynamics, and antitumor activity of SAR439459, a TGFβ inhibitor, as monotherapy and in combination with cemiplimab in patients with advanced solid tumors: Findings from a phase 1/1b study

    Safety, pharmacokinetics, pharmacodynamics, and antitumor activity of SAR439459, a TGFβ inhibitor, as monotherapy and in combination with cemiplimab in patients with advanced solid... by Joaquina C. Baranda, Debbie Robbrecht, Ryan Sullivan, Bernard Doger, Armando Santoro, Minal Barve, Jean‐Jacques Grob, Oliver Bechter, Maria Vieito, Maria Jose deMiguel, Dirk Schadendorf, Melissa Johnson, Clemence Pouzin, Cathy Cantalloube, Rui Wang, Jooyun Lee, Xiaofei Chen, Brigitte Demers, Amele Amrate, Giovanni Abbadessa, F. Stephen Hodi

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: